Latest Ratios: P/E Ratio 23.5x · EV/EBITDA 15.8x · ROE 9.6%. (2000–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $466M | $397M | $475M | $450M | $611M | $708M | $1.2B | $1.5B | $1.7B | $1.3B | $1.0B |
| Enterprise Value | $429M | $360M | $444M | $513M | $675M | $816M | $1.3B | $1.5B | $1.7B | $1.3B | $1.0B |
| P/E Ratio → | 23.50 | 20.01 | — | — | — | — | — | 30.11 | 52.72 | 34.60 | 27.13 |
| P/S Ratio | 0.72 | 0.61 | 0.72 | 0.76 | 0.51 | 0.67 | 1.11 | 1.28 | 1.57 | 1.20 | 1.10 |
| P/B Ratio | 2.24 | 1.91 | 2.35 | 2.14 | 2.72 | 3.12 | 4.61 | 5.34 | 6.43 | 5.27 | 4.77 |
| P/FCF | 24.05 | 20.50 | 22.05 | — | 15.10 | 331.94 | 67.24 | 27.55 | 50.99 | 73.22 | 25.71 |
| P/OCF | 21.65 | 18.45 | 19.44 | — | 12.16 | 52.19 | 40.83 | 21.16 | 35.19 | 20.77 | 16.64 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.55 | 0.67 | 0.86 | 0.57 | 0.77 | 1.20 | 1.27 | 1.58 | 1.21 | 1.11 |
| EV / EBITDA | 15.82 | 13.28 | 15.66 | 14.67 | 24.77 | 106.53 | 26.29 | 18.45 | 24.38 | 18.59 | 14.83 |
| EV / EBIT | 21.86 | 14.02 | 35.37 | 35.52 | — | 607.82 | — | 23.63 | 29.92 | 22.34 | 16.82 |
| EV / FCF | — | 18.56 | 20.61 | — | 16.69 | 382.24 | 72.27 | 27.52 | 51.40 | 74.01 | 25.85 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 9.8% | 9.8% | 10.2% | 10.5% | 6.1% | 5.4% | 8.5% | 10.7% | 10.4% | 10.6% | 11.5% |
| Operating Margin | 3.0% | 3.0% | 2.7% | 3.0% | 0.9% | -0.9% | 3.0% | 5.8% | 5.3% | 5.5% | 6.5% |
| Net Profit Margin | 3.1% | 3.1% | -0.2% | -1.4% | -0.5% | -1.1% | -1.3% | 3.1% | 3.0% | 3.5% | 4.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 9.6% | 9.6% | -0.6% | -3.8% | -2.8% | -4.9% | -5.0% | 13.3% | 12.7% | 16.2% | 18.9% |
| ROA | 6.7% | 6.7% | -0.4% | -2.2% | -1.5% | -2.7% | -3.3% | 9.7% | 8.8% | 10.8% | 12.4% |
| ROIC | 8.6% | 8.6% | 6.0% | 4.7% | 2.6% | -2.2% | 7.6% | 18.4% | 16.0% | 18.6% | 20.8% |
| ROCE | 8.5% | 8.5% | 6.7% | 6.0% | 3.5% | -3.1% | 10.3% | 24.3% | 22.2% | 25.5% | 30.1% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.11 | 0.11 | 0.13 | 0.31 | 0.30 | 0.48 | 0.36 | 0.02 | 0.06 | 0.08 | 0.09 |
| Debt / EBITDA | 0.87 | 0.87 | 0.92 | 1.87 | 2.43 | 14.26 | 1.91 | 0.07 | 0.22 | 0.29 | 0.28 |
| Net Debt / Equity | — | -0.18 | -0.15 | 0.30 | 0.29 | 0.47 | 0.34 | -0.01 | 0.05 | 0.06 | 0.03 |
| Net Debt / EBITDA | -1.39 | -1.39 | -1.10 | 1.81 | 2.36 | 14.02 | 1.83 | -0.02 | 0.20 | 0.20 | 0.08 |
| Debt / FCF | — | -1.94 | -1.45 | — | 1.59 | 50.30 | 5.03 | -0.03 | 0.42 | 0.79 | 0.14 |
| Interest Coverage | 31.02 | 31.02 | 4.34 | 5.79 | -0.65 | 1.68 | -12.71 | 68.04 | 69.09 | 57.08 | 81.55 |
Net cash position: cash ($61M) exceeds total debt ($23M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.47 | 2.47 | 2.17 | 1.63 | 1.23 | 1.33 | 1.28 | 1.41 | 1.30 | 1.03 | 1.23 |
| Quick Ratio | 1.92 | 1.92 | 1.70 | 1.15 | 0.85 | 0.98 | 0.89 | 1.00 | 0.94 | 0.77 | 0.94 |
| Cash Ratio | 1.01 | 1.01 | 0.78 | 0.03 | 0.02 | 0.02 | 0.04 | 0.09 | 0.02 | 0.06 | 0.13 |
| Asset Turnover | — | 2.22 | 2.20 | 1.54 | 3.09 | 2.37 | 2.47 | 3.06 | 2.96 | 2.95 | 2.85 |
| Inventory Turnover | 17.40 | 17.40 | 17.38 | 13.48 | 28.80 | 24.50 | 23.20 | 28.94 | 27.83 | 31.14 | 26.00 |
| Days Sales Outstanding | — | 19.11 | 23.64 | 37.71 | 18.09 | 33.08 | 27.55 | 19.36 | 23.35 | 23.67 | 27.35 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 3.1% | 3.6% | 1.9% | 2.3% | 3.3% | 2.9% | 1.6% | 1.2% | 1.0% | 1.2% | 1.3% |
| Payout Ratio | 72.2% | 72.2% | — | — | — | — | — | 47.9% | 51.6% | 42.1% | 36.6% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 4.3% | 5.0% | — | — | — | — | — | 3.3% | 1.9% | 2.9% | 3.7% |
| FCF Yield | 4.2% | 4.9% | 4.5% | — | 6.6% | 0.3% | 1.5% | 3.6% | 2.0% | 1.4% | 3.9% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 3.1% | 3.6% | 1.9% | 2.3% | 3.3% | 2.9% | 1.6% | 1.2% | 1.0% | 1.2% | 1.3% |
| Shares Outstanding | — | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $17M |
Margin and commodity volatility
According to current market data, Calavo trades at a P/S of 0.72 and a forward P/E of 18.50, suggesting that investors are pricing the company as a low-margin distributor rather than a high-growth consumer packaged goods entity, despite the potential for margin expansion in processed segments.
The valuation gap relative to diversified food processors appears to stem from the inherent volatility of the avocado crop cycle and the company's recent top-line contraction. Investors should monitor whether the forward P/E multiple of 18.50 is justified by the success of 'Project Uno' or if the market will continue to apply a discount due to the persistent underperformance of the Renaissance Food Group segment.
Based on reported financial statements, ROIC has struggled to maintain positive territory, frequently dipping into negative values such as the -0.6% recorded in 2026Q1, which indicates that the company is currently failing to generate returns that exceed its cost of capital.
The decay in return on invested capital appears driven by the combination of thin gross margins and the high fixed-cost burden of the fresh-cut processing facilities. This trend warrants further investigation into whether the current asset base is appropriately sized for the company's reduced revenue throughput or if further impairment charges are likely.
As reported in recent quarterly filings, the cash conversion cycle has exhibited significant volatility, peaking at 53 days in 2024Q1 and remaining inconsistent, which suggests that the company faces ongoing challenges in managing its inventory of highly perishable goods against its customer collection cycles.
The fluctuation in the CCC highlights the difficulty of balancing 'just-in-time' delivery requirements with the need to minimize spoilage in the Fresh segment. Investors should monitor whether the recent efforts to consolidate facilities will lead to a more stable and efficient working capital profile or if the current operational structure remains inherently prone to inventory-related cash drains.
Compared to direct peers like Mission Produce, which trades at a lower EV/EBITDA of 9.45, Calavo's current multiple of 15.82 appears elevated, suggesting that the market may be overestimating the stability of the company's processed food segment relative to its commodity-linked distribution business.
The valuation premium relative to Mission Produce may be misplaced if the market fails to account for the structural drag of the labor-intensive RFG division. This gap warrants further investigation into whether Calavo's sourcing advantages are truly superior or if the company is simply carrying higher overhead costs that compress its competitive positioning.
The most commonly misapplied metric for this business model is top-line revenue growth, which often obscures the underlying margin compression caused by commodity price volatility and the high-cost structure of the fresh-cut segment, as evidenced by the recent -1.98% revenue trend.
Analysts should instead focus on the 'field-to-market' spread and segment-specific operating margins, as these provide a clearer picture of true earning power than aggregate revenue. Relying on revenue growth in a commodity-linked distribution business can lead to a false sense of security during periods of high fruit prices, even when actual volume throughput and profitability are declining.
Includes 30+ ratios · 26 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CVGW stock.
Calavo Growers, Inc.'s current P/E ratio is 23.5x. The historical average is 27.4x. This places it at the 44th percentile of its historical range.
Calavo Growers, Inc.'s current EV/EBITDA is 15.8x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 16.5x.
Calavo Growers, Inc.'s return on equity (ROE) is 9.6%. The historical average is 10.7%.
Based on historical data, Calavo Growers, Inc. is trading at a P/E of 23.5x. This is at the 44th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Calavo Growers, Inc.'s current dividend yield is 3.06% with a payout ratio of 72.2%.
Calavo Growers, Inc. has 9.8% gross margin and 3.0% operating margin.
Calavo Growers, Inc.'s Debt/EBITDA ratio is 0.9x, indicating low leverage. A ratio below 2x is generally considered financially healthy.